Ajouter à une liste

Instrument Inactif

Communiqués Avigen, Inc.

Actions

US0536901038

Installations et services en soins de santé

Cours en clôture Nasdaq
- ^USD	-

Communiqués

30/11/-1	AVIGEN : Beacon Equity Issues Technical Trade Alerts on Market Movers: AAPL, ICOG, NKTR, STSI, HA, AVGN	PR
30/11/-1	AVIGEN : Avigen, Inc. Announces Second Quarter 2008 Earnings Conference Call	PR
30/11/-1	Avigen : Avigen, Inc. Announces First Quarter 2008 Earnings Conference Call	PR
30/11/-1	Avigen : Dutton Associates Announces Investment Opinion: Avigen Speculative Buy Rating In Update Coverage By Dutton Associates	BU
30/11/-1	Avigen : Dutton Associates Announces Investment Opinion: Avigen Speculative Buy Rating in Update Coverage by Dutton Associates	BU
30/11/-1	Avigen : Dutton Associates Announces Investment Opinion: Avigen Speculative Buy Rating in Initiating Coverage by Dutton Associates	BU
30/11/-1	AVIGEN : Biotechnology Value Fund, L.P. Announces Overwhelming Support to Remove the Board of Directors of Avigen, Inc. at Special Meeting of Stockholders	PR
30/11/-1	AVIGEN : Leading Advisory Firm, PROXY Governance, Recommends Avigen Shareholders Vote on GOLD Card to Remove Incumbent Directors and Elect BVF's Stockholder-Oriented Nominees	PR
30/11/-1	AVIGEN : Empirical Search Strategies Seeks Downside Protection Option at Avigen, Inc.	PR
30/11/-1	AVIGEN : BVF Acquisition LLC Increases Tender Offer Price for Avigen, Inc. to $1.20 Per Share	PR
30/11/-1	AVIGEN : Biotechnology Value Fund Urges Stockholders to Remove and Replace Current Board of Avigen, Inc. in an Effort to Protect and Maximize Stockholder Value	PR
30/11/-1	AVIGEN : BVF Acquisition LLC Extends Avigen Tender Offer to April 3, 2009	PR
30/11/-1	AVIGEN : BVF Acquisition LLC Extends Avigen Tender Offer to March 6, 2009	PR
30/11/-1	AVIGEN : Biotechnology Value Fund, L.P. Requests Avigen Board to Provide Critical Information to Stockholders	PR
30/11/-1	AVIGEN : BVF Warns Stockholders: Avigen Continues To Remain Silent on Downside Protection	PR
30/11/-1	AVIGEN : BVF Acquisition LLC, a Wholly-Owned Subsidiary of Biotechnology Value Fund, L.P., Commences Tender Offer for Any and All Outstanding Shares of Avigen at $1.00 Per Share	PR
30/11/-1	AVIGEN : Biotechnology Value Fund, L.P. To Make Tender Offer For Any And All Outstanding Shares Of Avigen At $1.00 Per Share	PR
30/11/-1	AVIGEN : Biotechnology Value Fund, L.P. Calls Special Meeting of Avigen Stockholders To Remove Incumbent Directors and Elect Slate of Stockholder-Focused Nominees	PR

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Articles Zonebourse Analyses Zonebourse

Filtres

Tous les transcripts sur plus de 9000 sociétés, le jour de leur publication !

Débloquez-les Maintenant !

Débloquez-les Maintenant !

×